These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22663952)

  • 1. Atypical presentation of tardive dyskinesia associated with risperidone long-acting injection as maintenance treatment in bipolar affective disorder: a case report.
    Chung AK
    Curr Drug Saf; 2012 Feb; 7(1):21-3. PubMed ID: 22663952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder.
    Yatham LN; Fallu A; Binder CE
    Acta Psychiatr Scand Suppl; 2007; (434):50-6. PubMed ID: 17688463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paliperidone extended-release as adjunctive therapy to lithium or valproate in the treatment of acute mania: a randomized, placebo-controlled study.
    Berwaerts J; Lane R; Nuamah IF; Lim P; Remmerie B; Hough DW
    J Affect Disord; 2011 Mar; 129(1-3):252-60. PubMed ID: 20947174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
    Ouyang WC; Hsu MC; Yeh IN; Kuo CC
    Int J Psychiatry Clin Pract; 2012 Sep; 16(3):178-88. PubMed ID: 22404731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic evidence for manic episode].
    Terao T
    Seishin Shinkeigaku Zasshi; 2011; 113(9):867-72. PubMed ID: 22117391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risperidone long-acting injection: in bipolar I disorder.
    Deeks ED
    Drugs; 2010 May; 70(8):1001-12. PubMed ID: 20481656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Acting Injectable Second-Generation/Atypical Antipsychotics for the Management of Bipolar Disorder: A Systematic Review.
    Keramatian K; Chakrabarty T; Yatham LN
    CNS Drugs; 2019 May; 33(5):431-456. PubMed ID: 30963507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in tardive dyskinesia with aripiprazole use.
    Witschy JK; Winter AS
    Can J Psychiatry; 2005 Mar; 50(3):188. PubMed ID: 15830835
    [No Abstract]   [Full Text] [Related]  

  • 10. Two cases of bipolar disorder successfully stabilized for five years with a low dose of risperidone and lithium.
    Yoshimura R; Ueda N; Shinkai K; Nakamura J
    Pharmacopsychiatry; 2006 Nov; 39(6):233-4. PubMed ID: 17124648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics.
    Woo YS; Bahk WM; Jung YE; Jeong JH; Lee HB; Won SH; Lee KH; Jon DI; Yoon BH; Kim MD; Min KJ
    Psychiatry Clin Neurosci; 2014 Jun; 68(6):418-24. PubMed ID: 24506520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
    Miller DS; Yatham LN; Lam RW
    J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risperidone in acute and continuation treatment of mania.
    Yatham LN; Binder C; Riccardelli R; Leblanc J; Connolly M; Kusumakar V;
    Int Clin Psychopharmacol; 2003 Jul; 18(4):227-35. PubMed ID: 12817157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone-induced tardive dyskinesia and parkinsonism.
    Gwinn KA; Caviness JN
    Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder.
    Gigante AD; Lafer B; Yatham LN
    CNS Drugs; 2012 May; 26(5):403-20. PubMed ID: 22494448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania.
    Yatham LN; Binder C; Kusumakar V; Riccardelli R
    Int Clin Psychopharmacol; 2004 Mar; 19(2):103-9. PubMed ID: 15076019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder.
    Fagiolini A; Casamassima F; Mostacciuolo W; Forgione R; Goracci A; Goldstein BI
    Expert Opin Pharmacother; 2010 Jul; 11(10):1727-40. PubMed ID: 20486830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and safety of combination therapy with lithium and risperidone.
    Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W
    Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646
    [No Abstract]   [Full Text] [Related]  

  • 19. Rabbit syndrome induced by combined lithium and risperidone.
    Mendhekar DN
    Can J Psychiatry; 2005 May; 50(6):369. PubMed ID: 15999955
    [No Abstract]   [Full Text] [Related]  

  • 20. Identifying Profiles of Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With a Long-Acting Injectable Antipsychotic.
    Tohen M; Goldberg JF; Hassoun Y; Sureddi S
    J Clin Psychiatry; 2020 Jun; 81(4):. PubMed ID: 32558403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.